UH Rainbow Babies and Children's Hospital, Pediatric Critical Care, Cleveland, OH, USA; Willis-Knighton Health System, Pediatric Critical Care, Shreveport, LA, USA.
UH Rainbow Babies and Children's Hospital, Pediatric Critical Care, Cleveland, OH, USA; Case Western Reserve University School of Medicine, Pediatrics, Cleveland, OH, USA.
Thromb Res. 2018 Jan;161:73-77. doi: 10.1016/j.thromres.2017.11.014. Epub 2017 Nov 22.
The incidence of venous thromboembolism (VTE) is rising among inpatients in US hospitals, especially among kids with central venous catheters (CVCs) in the pediatric intensive care unit (PICU).
To identify a sub-group of "VTE-rich" population among PICU children, and to assess the effect of VTE on morbidity and mortality.
Data was extracted from a multicenter Virtual PICU Database, or VPS, for children with a CVC and presence of a VTE. The primary outcome variable was all cause mortality and secondary outcome measure was prolonged mechanical ventilation. Primary diagnoses and Pediatric risk of mortality 2 (PIM 2) score were also recorded.
The database identified 158,299 PICU patients who had a CVC. A total of 1602 patients had VTE (103 per 10,000 PICU patients). Multivariate analysis showed increased risk of VTE in patients who were <1year old (OR 1.48; 1.30-1.68), mechanically ventilated (OR 2.48; 2.07-2.98), had either a diagnostic (OR 2.32; 1.94-2.78) or therapeutic cardiac catheterization (OR 2.06; 1.66-2.55), PICC (OR 3.91; 3.50-4.37), and percutaneous CVC (OR 3.99; 3.48-4.61). Primary diagnoses associated with VTE were endocrinologic, immunologic, and gastrointestinal disorders. PICU patients with CVC and VTE had increased odds of mortality (OR 1.71; 1.47-2.00) after adjusting for factors associated with mortality, and fewer Ventilator Free Days (VFD) than patients without VTE.
Critically ill children with CVC have a significant risk of developing VTE. Identification of the above "VTE-rich" population may aid in design of clinical trials aimed at prevention of VTE among hospitalized PICU children.
美国医院住院患者静脉血栓栓塞症(VTE)的发病率上升,尤其是儿科重症监护病房(PICU)中带有中心静脉导管(CVC)的儿童。
确定 PICU 患儿中“VTE 高发”人群亚组,并评估 VTE 对发病率和死亡率的影响。
从多中心虚拟 PICU 数据库(VPS)中提取数据,该数据库包含 CVC 并存在 VTE 的患儿。主要结局变量为全因死亡率,次要结局测量为机械通气延长。还记录了主要诊断和儿科死亡率 2 评分(PIM 2)。
该数据库确定了 158299 名有 CVC 的 PICU 患儿。共有 1602 例患儿发生 VTE(每 10000 例 PICU 患儿中有 103 例)。多变量分析显示,1 岁以下(OR 1.48;1.30-1.68)、机械通气(OR 2.48;2.07-2.98)、有诊断性(OR 2.32;1.94-2.78)或治疗性心导管插入术(OR 2.06;1.66-2.55)、PICC(OR 3.91;3.50-4.37)和经皮 CVC(OR 3.99;3.48-4.61)的患儿 VTE 风险增加。与 VTE 相关的主要诊断是内分泌、免疫和胃肠道疾病。在调整与死亡率相关的因素后,患有 CVC 和 VTE 的 PICU 患儿的死亡率(OR 1.71;1.47-2.00)更高,且无 VTE 患儿的呼吸机无天数(VFD)更少。
患有 CVC 的危重症儿童发生 VTE 的风险显著增加。确定上述“VTE 高发”人群可能有助于设计旨在预防住院 PICU 患儿 VTE 的临床试验。